WS #13354

From 500 msgs · 9 key-dev

AstraZeneca (AZN) fell up to 7% on reports of early merger talks with Bristol-Myers Squibb (BMY), which would create the world's 4th-largest drugmaker (~$400B).

Pharma mega-merger speculation: AZN-BMY

AstraZeneca (AZN) fell up to 7% on reports of early merger talks with Bristol-Myers Squibb (BMY), which would create the world's 4th-largest drugmaker (~$400B).

Full world state #13354 →